Journal of Pharmaceutical and Biomedical Sciences

Quality-Adjusted Life Years (QALYs) of Tuberculosis Patients in the Intensive and Continuous Phase in a Private Hospital of Yogyakarta, Indonesia

Dewi Oktavia, Dyah Aryani Perwitasari, Woro Supadmi

Abstract


Context Tuberculosis is a disease with low quality of life (QoL) and quality-adjusted life years (QALYs) due to illness, impairment of health conditions and death. QALYs combine the QoL as well as quantity of life with value judgments utility of individuals or society.
Aims To compare the QoL and QALYs of tuberculosis patients between treatment on the
intensive and the continuous phase.
Settings and Design This study used cohort design in a private hospital of Yogyakarta.
Subjects were patients with newly diagnosed pulmonary tuberculosis and aged between
20 and 80 years.
Materials and Methods Data was collected using Indonesian version of St. George Respiratory questionnaire (SGRQ) and using the scenario time trade off method (TTO) at the end of 1st, 2nd, and 3rd month treatment. The score obtained was used to measure patients’ QoL and QALYs during the treatment phase.
Statistical Analysis To determine the differences of QoL and QALY in the intensive and continuous phase we used the paired samples t-test.
Results The average score of total QoL of tuberculosis patients using the SGRQ was 45.90% in intensive phase and 17.43% in the continuous phase (p < 0.05). While the average of QALYs values was 0.74 QALYs in intensive phase and 0.87 in the continuous phase (p < 0.05).
Conclusions Patients with pulmonary tuberculosis undergoing treatment with oral antituberculosis gain 0.74 QALY in the intensive phase and 0.87 QALY in continuous phase. Tuberculosis patients’ QoL and QALY are better in the continuous phase than ones in the intensive phase.

Keywords


QALY, quality of life, tuberculosis, Indonesia

Full Text:

References


National Health Institute. Pedoman Nasional PenanggulanganTuberkulosis, 2nd ed. National Health Institute; 2007.

http://www.who.int/tb/data. Global Tuberkulosis Control 2010. Accessed on 3 November 2014.

Indonesian Monistry of Health. Pedoman Nasional Pengendalian Tuberkulosis. Jakarta; 2011.

Miller TL, McNabb SJN, Hilsenrath P, Pasipanodya J, Weis SE. Personal and societal health quality lost to tuberculosis. PloS ONE. 2009;4:1–6.

Othman GQ, Ibrahim MIM, Raja YA. Health related quality of life of pulmonary and extrapulmonary tuberculosis patient in Yeman. Afr J Pharm Pharmacol. 2011;5:547–53.

Duhria M, Sharma N, Ingle GK. Impact of tubercolusis on the quality of life. Indian J Community Med. 2008;33:58–9.

Aggarwal AN. Health-related quality of life: a neglected aspect of pulmonary tuberculosis. Lung India. 2010;27:1–3.

Arnesen T, Trommald M. Are QALYs based on time trade-off comparable? A systematic review of TTO methodologies. Health Econ. 2005;14:39–53.

Sharma PR, Jain S, Bamezai RNK, Tiwari PK. Increased prevalence of pulmonary tuberculosis in male adults of Sahariya tribe of India: a revised survey. Indian J Community Med. 2010;35:267–71.

Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary Med. 2013. http://dx.doi.org/10.1155/2013/828939

Aggarwal AN, Gupta D, Janmeja AK, Jindal SK. Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions. Int J Tuberc Lung Dis. 2013;17:947–53

Rajeswari R, Muniyandi M, Balasubramanian R, Narayanan PR. Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from South India. Soc Sci Med. 2005;60:1845–53.

Kruijshaar ME, Lipman M, Essink-Bot M-L, et al. Health status of UK patients with active tuberculosis. Int J Tuberc Lung Dis.2010;14:296–302.

Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest. 2008;133:396–403.

Guo N, Marra F, Fitzgerald JM, Elwood RK, Marra CA. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. Eur Respir J. 2010;36:206–8.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.